BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35350159)

  • 1. A Review of Extended and Continuous Infusion Beta-Lactams in Pediatric Patients.
    Imburgia TA; Kussin ML
    J Pediatr Pharmacol Ther; 2022; 27(3):214-227. PubMed ID: 35350159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of beta-lactam antibiotics.
    MacGowan AP; Bowker KE
    Clin Pharmacokinet; 1998 Nov; 35(5):391-402. PubMed ID: 9839090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacodynamics of Prolonged Infusion β-Lactams for the Treatment of Pseudomonas aeruginosa Infections: A Systematic Review.
    Thabit AK; Hobbs ALV; Guzman OE; Shea KM
    Clin Ther; 2019 Nov; 41(11):2397-2415.e8. PubMed ID: 31679822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous and extended infusions of β-lactam antibiotics in the pediatric population.
    Walker MC; Lam WM; Manasco KB
    Ann Pharmacother; 2012 Nov; 46(11):1537-46. PubMed ID: 23115223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary.
    Hong LT; Downes KJ; FakhriRavari A; Abdul-Mutakabbir JC; Kuti JL; Jorgensen S; Young DC; Alshaer MH; Bassetti M; Bonomo RA; Gilchrist M; Jang SM; Lodise T; Roberts JA; Tängdén T; Zuppa A; Scheetz MH
    Pharmacotherapy; 2023 Aug; 43(8):736-739. PubMed ID: 37615244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists.
    Hong LT; Downes KJ; FakhriRavari A; Abdul-Mutakabbir JC; Kuti JL; Jorgensen S; Young DC; Alshaer MH; Bassetti M; Bonomo RA; Gilchrist M; Jang SM; Lodise T; Roberts JA; Tängdén T; Zuppa A; Scheetz MH
    Pharmacotherapy; 2023 Aug; 43(8):740-777. PubMed ID: 37615245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.
    Prescott WA; Gentile AE; Nagel JL; Pettit RS
    P T; 2011 Nov; 36(11):723-63. PubMed ID: 22346306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
    Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
    Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models.
    Dhaese S; Heffernan A; Liu D; Abdul-Aziz MH; Stove V; Tam VH; Lipman J; Roberts JA; De Waele JJ
    Clin Pharmacokinet; 2020 Oct; 59(10):1237-1250. PubMed ID: 32710435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach.
    Maguigan KL; Al-Shaer MH; Peloquin CA
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics.
    Chen M; Buurma V; Shah M; Fahim G
    Am J Health Syst Pharm; 2019 Sep; 76(18):1383-1394. PubMed ID: 31505562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Infusion of Beta-Lactams Is Associated With Improved Outcomes in Pediatric Patients.
    Zembles TN; Schortemeyer R; Kuhn EM; Bushee G; Thompson NE; Mitchell ML
    J Pediatr Pharmacol Ther; 2021; 26(2):187-193. PubMed ID: 33603583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.
    Lee YR; Miller PD; Alzghari SK; Blanco DD; Hager JD; Kuntz KS
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):155-170. PubMed ID: 29027128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.
    De Waele JJ; Lipman J; Akova M; Bassetti M; Dimopoulos G; Kaukonen M; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Udy AA; Starr T; Wallis SC; Roberts JA
    Intensive Care Med; 2014 Sep; 40(9):1340-51. PubMed ID: 25053248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
    Fuchs A; Li G; van den Anker JN; Bielicki J
    Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation.
    MacVane SH; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2014 Feb; 43(2):105-13. PubMed ID: 24359838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.
    Burgess SV; Mabasa VH; Chow I; Ensom MH
    Ann Pharmacother; 2015 Mar; 49(3):311-22. PubMed ID: 25575975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.